CDT Equity Inc. (CDT): Nasdaq/NYSE listing notice — CDT Equity receives Nasdaq deficiency letter for late Q1 10-Q filing; has until July 20 to submit plan
CDT Equity Inc.
Received Nasdaq deficiency notice on May 21, 2026 for failing to timely file Q1 2026 Form 10-Q under Listing Rule 5250(c)(1).
No immediate effect on listing or trading of common stock (CDT) or warrants (CDTTW).
Must submit a plan to regain compliance by July 20, 2026.
Company anticipates filing Form 10-Q shortly upon completion of the current draft review.
CDT Equity Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
late filing
Rules
5250(c)(1)
Exact text from the filing
May 21, 2026, CDT Equity Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Periodic Filing Requirement”) because the Company did not file its Quarterly Report on Form 10-Q for the three-month period ended March 31, 2026 (the “Form 10-Q”) in a timely manner, as required for continued listing on The Nasdaq Capital Market. The Notice has no immediate effect on the listing or trading of the Company’s
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.